Short description
Clinical Genomics develops innovative products for colorectal cancer diagnosis.
Description
Clinical Genomics is a privately held biotechnology company developing innovative products for colorectal cancer diagnosis and monitoring. With a broad intellectual property portfolio including more than 20 issued and pending patents, Clinical Genomics has developed and validated a sensitive and specific blood test for colorectal cancer recurrence monitoring that will be launched in the U.S. in 2016. This 2-gene test, which is based on methylated DNA from two genes, BCAT1 and IKZF1, is currently known by its project name GEMINI.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Sydney, New South Wales, Australia, Oceania
Founded on
January 1, 2006
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$7890 - 12340
Sign in for full access
Investors
Cannot Access, Cannot Access, Noway Youcantaccess
Sign in for full access
Founders
Lawrence LaPointe, Richard J. Sands